Oculis finishes PREDICT-1 randomization with 176 patients, putting a genotype-guided dry eye readout on the 2026 calendar
Market Chameleon (Tue, 20-Oct 11:50 AM)
Oculis: Precision-Medicine Pipeline Progress Supports Reiterated Buy Rating and Unchanged $39 Price Target
at www.tipranks.com (Tue, 20-Oct 11:05 AM)
